Intelligent Robotic Interactions for Children With Autism Spectrum Disorders (I-ROBI)

August 7, 2023 updated by: University Hospital, Montpellier

Adapted and Individualized Intelligent Robotic Interactions to the Ability Spectrum of Children With Autism Spectrum Disorder

For several years, studies have been developed on the contribution of social robots as a tool for interventions for children with autism spectrum disorders (ASD). One of the recommended intervention models is the ESDM (Early Start Denver Model). It consists of setting up an individualized, intensive program (at least 20 hours per week) through the pleasure of play. The teacher follows the motivation and interests of the child, and it is the child who chooses the activities. Studies published in recent years tend to show that robots bring benefits to ASD children, particularly in the treatment of social interactions and in clinical settings. However, there is no scientific consensus on the generalized contribution and effect over time of these interventions. Moreover, a robotic solution controlled by a practitioner through a telepresence system allows for a better adaptability to the responses and desires of the children during the interventions. The investigators believe that such a solution would allow for better assessment of progress in the core skills of expressive communication and imitation and greater engagement during interventions.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Montpellier, France
        • Hôpital La Colombière - CHU de Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient living in the Hérault department (France),
  • Patient with a diagnosis of ASD confirmed by a psychiatrist or a psychologist and receiving current care according to the ESDM model in the MPEA Peyre Plantade child psychiatry service.

Exclusion Criteria:

  • Patients

    • Failure to obtain written informed consent after a cooling-off period
    • Participating in another type of program other than ESDM
    • Not being affiliated to a French social security system or being a beneficiary of such a system
  • Therapist

    • History of epilepsy for health professionals (therapists)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Children with autism spectrum disorders

Phase A

  • 4 individual sessions (1 per week)
  • Additional time of 15 minutes to evaluate 3 selected tasks of the ESDM
  • Satisfaction Evaluation - Parent
  • Satisfaction Evaluation - Therapist

Phase B :

  • 11 sessions (1 per week)
  • Additional time of 15 minutes to evaluate 3 selected tasks of the ESDM with the help of the robot Pepper
  • Satisfaction Evaluation - Parent
  • Satisfaction Evaluation - Therapist

Phase C :

  • 4 sessions (1 per week)
  • Additional time of 15 minutes to evaluate 3 selected tasks of the ESDM without the help of the robot Pepper
  • Satisfaction Evaluation - Parent
  • Satisfaction Evaluation - Therapist
  • All sessions will also be filmed and recorded

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of success on the selected task in the ESDM program
Time Frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Measure the success score for the selected task using the ESDM scoring grid. As soon as the child successfully completes one of the different learning stages, a success score is given to the task. This score will be maximum if all the learning stages of the task considered have been reached (Task 1 = 6 learning stages (maximum score =6); Tasks 2 and 3 = 7 stages (maximum score =7)). The ESDM scoring grid will be completed by the research therapists at the end of each session.
From phase A (baseline) to phase C (post-intervention) = 19 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of the child's viewing and movement of the head and body towards the robot (task 1: saying "hello")
Time Frame: During Phase B = 11 weeks

Measurement of the viewing and movement times toward the robot, as well as the response time from the analysis of the videos made during the sessions using the Pepper robot.

Data from the robot: - Video recording by camera of the sessions of the whole room (camera independent of the robot) - Video return by the camera installed on the robot - Audio feedback from the therapist, the robot and the child.

During Phase B = 11 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of the child's viewing and movement of the head and body towards the therapist (task 1: saying "hello")
Time Frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks

Measurement of the viewing and movement times toward the therapist, as well as the response time from the analysis of the videos made during the sessions using the Pepper robot.

Data from the robot: - Video recording by camera of the sessions of the whole room (camera independent of the robot) - Video return by the camera installed on the robot - Audio feedback from the therapist, the robot and the child.

From phase A (baseline) to phase C (post-intervention) = 19 weeks
Response time of the child after the presentation of the imitation exercise (task 2: action imitation)
Time Frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Measurement of the child's response time during the imitation exercise
From phase A (baseline) to phase C (post-intervention) = 19 weeks
Number of objects given to the robot (task 3 : give an object on verbal request)
Time Frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Measurement of the number of objects given out of the 5 requested (best score 5/5) in task 3.
From phase A (baseline) to phase C (post-intervention) = 19 weeks
Teleoperation success score for therapist (throught UX score)
Time Frame: Phase C (from week 5 to 15)
Measurement of the success score (UX) of the teleoperation using the videos of the Pepper robot and according to the successful tasks to be performed during the session (the child and the second practitioner in the room can clearly hear the robot's instructions, the robot's gestures are fluid and is able to point to objects with the hand…). If the therapist was able to initiate each task, the score is 3/3.
Phase C (from week 5 to 15)
Parent satisfaction score on current care
Time Frame: During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks).
Measurement of satisfaction score using a numerical satisfaction scale (EN). Parents will be asked about their current satisfaction with the care after each phase of the procedure. This will be rated on a scale of 0 to 10, (0 "I am not at all satisfied with the effectiveness of the proposed care" and 10 "I am totally satisfied with the care").
During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks).
Professional satisfaction score on current care.
Time Frame: During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks)
Measurement of satisfaction score using a numerical satisfaction scale (EN). Professionals will be asked about their current satisfaction with the care after each phase of the procedure. This will be rated on a scale of 0 to 10, (0 "I am not at all satisfied with the effectiveness of the proposed care" and 10 "I am totally satisfied with the care").
During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks)
Score of success in the ESDM tasks without teleoperation
Time Frame: During phase A (to 4 weeks), Phase C (from week 16 to 19
This score (observe/total) will be maximum if all the learning stages of the task in question have been reached (Task 1 = 6 learning stages (maximum score =6); Tasks 2 and 3 = 7 stages (maximum score = 7)). This scoring will be done by therapist at the end of each intervention, after the current care.
During phase A (to 4 weeks), Phase C (from week 16 to 19
Score of success in the ESDM tasks with teleoperation
Time Frame: During phase B (from week 5 to 15)
This score (observe/total) will be maximum if all the learning stages of the task in question have been reached (Task 1 = 6 learning stages (maximum score =6); Tasks 2 and 3 = 7 stages (maximum score =7)).The robotics analyses will be performed by a robotic engineer of the LIRMM independent to the project.
During phase B (from week 5 to 15)
Teleoperation usability score for therapist (throught UMUX score)
Time Frame: During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks)
A User Experience Questionnaire (UMUX) was administered at weeks 5, 10 and 15 to assess the quality and ease of use of the teleoperation system over time. The questionnaires are evaluated on a scale from 0 (minimum score) to 10 (maximum score). 0=Not at all satisfied 10= Totally satisfied
During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2023

Primary Completion (Estimated)

February 15, 2025

Study Completion (Estimated)

August 15, 2025

Study Registration Dates

First Submitted

July 28, 2023

First Submitted That Met QC Criteria

August 7, 2023

First Posted (Actual)

August 15, 2023

Study Record Updates

Last Update Posted (Actual)

August 15, 2023

Last Update Submitted That Met QC Criteria

August 7, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Early Start Denver Model (ESDM)

3
Subscribe